Iniciar sesión Regístrese gratis

Nymox Pharmaceutical Corp Objetivo de 1 año

¿Qué es el Objetivo de 1 año de Nymox Pharmaceutical Corp?

El Objetivo de 1 año de Nymox Pharmaceutical Corp es $9 +4,400.00%

¿Cuál es la definición de Objetivo de 1 año?

El objetivo de 1 año es el precio de las acciones previsto dentro de un año.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

Objetivo de 1 año de compañías en Sector Health Care en NASDAQ en comparadas con Nymox Pharmaceutical Corp

¿Qué hace Nymox Pharmaceutical Corp?

nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.

Empresas con objetivo de 1 año similar a Nymox Pharmaceutical Corp